Recommendations for follow-up care of individuals with an inherited predisposition to cancer: I. Hereditary nonpolyposis colon cancer

JAMA

Volumn 277, Issue 11, 1997, Pages 915-919

  Burke, Wylie ^a,m   Petersen, Gloria ^b,l   Lynch, Patrick ^c   Botkin, Jeffrey ^d   Daly, Mary ^e   Garber, Judy ^f   Kahn, Mary Jo Ellis ^g   McTiernan, Anne ^h   Offit, Kenneth ⁱ   Thomson, Elizabeth ^j   Varricchio, Claudette ^k  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e FOX CHASE CANCER CENTER   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g National Breast Cancer Coalition   (United States)

^h Fred Hutchinson Cancer Research Center   (United States)

ⁱ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^j NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^k NATIONAL CANCER INSTITUTE   (United States)

^l Oncormed Inc   (United States)

^m UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CHEMOPROPHYLAXIS; COLON CANCER; COLON RESECTION; COLONOSCOPY; ENDOMETRIUM CANCER; FAMILIAL CANCER; FOLLOW UP; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; HYSTERECTOMY; LIFESTYLE; PATIENT COUNSELING; PRIORITY JOURNAL; REVIEW; SALPINGOOOPHORECTOMY;

EID: 8044220285     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.11.915     Document Type: Review

References (50)

1. Lynch HT, Smyrk TC. Hereditary nonpolyposis colorectal cancer (Lynch syndrome): an updated review. Camer. 1996;78:1149-1167.
2. Mecklin J-P, Jarvinen HJ. Clinical features of colorectal carcinoma in cancer family syndrome. Dis Colon Rectum. 1986;29:160-164.
3. Marra G, Boland CR. Hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst. 1995;87:1114-1125.
4. Aarnio M, Mecklin J-P, Aaltonen LA, et al. Lifetime risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer. 1995;64:430-433.
5. US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Baltimore, Md: Williams & Wilkins; 1996.
6. Vasen HFA, Mecklin J-P, Meera Khan P, Lynch HT. Hereditary non-polyposis colorectal cancer. Lancet. 1991;338:877.
7. Liu B, Parsons RE, Hamilton SR, et al. hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res. 1994;54:4590-4594.
8. Papadopoulos N, Nicolaides NC, Wei Y-F, et al. Mutation of a mutL homolog in hereditary colon cancer. Science. 1994;263:1625-1629.
9. Nicolaides NC, Papadopoulos N, Liu B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature. 1994;371:75-80.
10. Rhyu MS. Molecular mechanisms underlying hereditary nonpolyposis colorectal carcinoma. J Natl Cancer Inst. 1996;88:240-251.
11. Liu B, Parsons R, Papadopoulos N, et al. Analysis of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients. Nat Med. 1996;2:169-174.
12. Lynch HT, Harris RE, Lynch PM, et al. Role of heredity in multiple primary cancer. Cancer. 1977;40:1849-1854.
13. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer. 1993;71:677-685.
14. Watson P, Vasen HFA, Mecklin J-P, et al. The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. Am J Med. 1994;96:516-520.
15. Vasen HFA, Offerhaus GJA, den Hartog Jager FCA, et al. The tumor spectrum in hereditary nonpolyposis colorectal cancer, a study of 24 kindreds in the Netherlands. Int J Cancer. 1990;46:31-34.
16. Jarvinen HJ, Mecklin J-P, Sistonen P. Screening reduced colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 1995;108:1405-1411.
17. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653-657.
18. Winawer SJ, Zauber AG, Ho MN, et al, and The National Polyp Study Workgroup. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977-1981.
19. Ahlquist DA. Aggressive polyps in hereditary nonpolyposis colorectal cancer targets for screening. Gastroenterology. 1995;108:1590-1592.
20. Vasen HFA, Nagengast FM, Meera Khan P. Interval cancers in hereditary non-polyposis colorectal cancer(Lynch syndrome). Lancet. 1995;345:1183-1184.
21. Brewer DA, Fung CLS, Chapuis PH, Bokey EL. Should relatives of patients with colorectal cancer be screened? Dis Colon Rectum. 1994;37:1328-1338.
22. Mecklin J-P, Jarvinen H. Treatment and follow-up strategies in hereditary nonpolyposis colorectal carcinoma. Dis Colon Rectum. 1993;36:927-929.
23. Vasen HFA, Mecklin J-P, Watson P, et al. Surveillance in hereditary nonpolyposis colorectal cancer. Dis Colon Rectum. 1993;36:1-4.
24. Osmers R, Volksen M, Schauer A. Vaginosonography for early detection of endometrial carcinoma? Lancet. 1990;335:1569-1571.
25. Osmers RGW, Kuhn W. Endometrial cancer screening. Curr Opin Obstet Gynecol. 1994;6:75-79.
26. Warner EA, Parson AK. Screening and early diagnosis of gynecologic cancers. Med Clin North Am. 1996;80:45-61.
27. Lynch HT, Lynch JF. 25 years of HNPCC. Anticancer Res. 1994;14:1617-1624.
28. Van den Bosch T, Van den Dael A, Van Schouboreck D, et al. Combining vaginal ultrasonography and office endometrial sampling in the diagnosis of endometrial disease in postmenopausal women. Obstet Gynecol. 1995;85:349-352.
29. Ben-Baruch G, Seidman DS, Schiff E, et al. Outpatient endometrial sampling with the Pipelle curette. Gynecol Obstet Invest. 1994;37:260-262.
30. Zorlu CG, Cobanoglu O, Isik AZ, et al. Accuracy of Pipelle endometrial sampling in endometrial carcinoma. Gynecol Obstet Invest. 1994;38:272-275.
31. Averette HE, Steren A, Nguyen HN. Screening in gynecologic cancers. Cancer. 1993;72(suppl 3):1043-1049.
32. Friedlander M, de Souza P, Segelov E. Risk factors, epidemiology, screening, and prognostic factors in female genital cancer. Curr Opin Oncol. 1992;4:913-922.
33. Partridge EE. Endometrial cancer. Surg Clin North Am. 1991;71:991-1004.
34. Fitzgibbons RJ, Lynch HT, Lanspa SJ, et al. Surgical strategies for management of the Lynch syndromes. In: Utsunomiya J, Lynch H, eds. Hereditary Colorectal Cancer. New York, NY: Springer-Verlag NY Inc; 1990:211-217.
35. Lynch HT, Lynch J. Natural history, molecular genetics, genetic counseling, surveillance, and management of HNPCC. J Tumor Marker Oncol. 1995; 10:7-31.
36. Burke W, Daly M, Garber J, et al for the Cancer Genetics Studies Consortium. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. JAMA. In press.
37. Lynch HT, Smyrk T, Lanspa SJ, et al. Flat adenomas in a colon cancer-prone kindred. J Natl Cancer Inst. 1988;80:278-282.
38. Mecklin J-P, Sipponen P, Jarvinen HJ. Histopathology of colorectal carcinomas and adenomas in cancer family syndrome. Dis Colon Rectum. 1986;29:849.
39. Jass JR, Stewart SM, Schroeder D, Lane MR. Screening for hereditary non-polyposis colorectal cancer in New Zealand. Bur J Gastroenterol Hepatol. 1992;4:523-527.
40. Hixson LJ, Fennerty MB, Sampliner RE, McGee D, Garewal H. Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J Natl Cancer Inst. 1990;82:1769-1772.
41. Lynch HG, Lynch JF. Clinical implications of advances in the molecular genetics of colorectal cancer. Tumori. 1995;81(3 suppl S0):19-29.
42. Lin HH, Chen CD, Chen CK, et al. Is total abdominal hysterectomy with bilateral salpingo-oophorectomy adequate for new FIGO stage I endometrial carcinoma? Br J Obstet Gynaecol. 1995;102:148-152.
43. Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1991;325:1593-1596.
44. Giovannucci E, Rimm EB, Stampfer MJ, et al. Aspirin use and the risk of colorectal cancer and adenoma in male health professionals. Ann Intern Med. 1994;121:241-246.
45. Giovannucci E, Egan KM, Hunter DG, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995;333:609-614.
46. Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med. 1993;328:1313-1316.
47. Nugent KP, Farmer KCR, Spigelman AD, Williams CB, Phillips RKS. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg. 1993;80:1618-1619.
48. Giovannucci E, Ascherio A, Rimm EB, et al. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med. 1995;122:327-334.
49. Potter JD, Slattery ML, Bostick R, Gapstor SM. Colon cancer. Epidemiol Rev. 1993;15:499-545.
50. NCI Cancer Genetics Network promises to widen testing, information access. Scientist July 22, 1996; 10:1,8.